GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Reading between the lines, could this mean that the partnership is a reality!<

It’s a matter of timing.

If GTC expects to ink a partnership deal in, say, mid April, the deal would have been later than the deadline for filing the annual-meeting proxy for the old meeting date in mid May. Hence, the old annual-meeting date would have left GTC no escape valve to ask shareholders for RS authorization in the event that the partnership deal did not materialize or did not lift the share price.

With the annual meeting moved to late June, if GTC can ink a partnership deal in April (or even early May), there is time to see how the deal affects the share price before deciding whether to ask shareholders for a RS authorization.